Xilio Therapeutics Inc. (XLO)
NASDAQ: XLO
· Real-Time Price · USD
0.70
-0.00 (-0.38%)
At close: Aug 15, 2025, 3:59 PM
0.70
-0.74%
After-hours: Aug 15, 2025, 06:54 PM EDT
Xilio Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -13.27M | -13.09M | -14.02M | -13.93M | -17.2M | -17.66M | -16.75M | -19.36M | -22.65M | -22.47M | -19.79M | -24.61M | -21.35M | -19.7M | -16.25M | -23.18M | -16.67M |
Depreciation & Amortization | 497K | 375K | 381K | 445K | 443K | 449K | 460K | 492K | 499K | 489K | 473K | 445K | 440K | 394K | 382K | 373K | 350K |
Stock-Based Compensation | 1.53M | 1.52M | 1.57M | 1.51M | 1.83M | 1.93K | 1.86M | 1.8M | 1.79M | 1.81M | 1.87M | 2.71M | 2.03M | 2.07M | 1.09M | 1M | 794K |
Other Working Capital | 40.8M | -4.56M | -36.07M | 1.41M | 34.73M | 2.27M | 492K | 1.21M | 1.36M | 423K | -2.77M | 5.05K | -1.18M | 1.21M | -2.59M | -3.18M | -4.43M |
Other Non-Cash Items | n/a | 2K | 34.74M | 1.89M | 33.02M | 3.28M | 23K | 87K | 31K | 59K | 59K | 53K | 53K | 56K | 198K | 88K | 53K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -1.34M | 1K | 2K | n/a | n/a | n/a | n/a | n/a | 4K | 155K | 48K | 15K |
Change in Working Capital | 40.21M | -2.96M | -36.35M | 31.92M | 4.43M | 1.83M | 1.03M | 400K | -4.92M | 1.88M | -2.52M | 4.65M | -2M | 18K | -6.14M | 1.58M | -7.26M |
Operating Cash Flow | 28.98M | -14.16M | -13.67M | 19.95M | -10.5M | -13.43M | -13.37M | -16.57M | -25.25M | -18.22M | -19.91M | -16.76M | -20.84M | -17.16M | -20.72M | -20.14M | -22.73M |
Capital Expenditures | -22K | -6K | -9K | -21K | n/a | n/a | n/a | -316K | -170K | -509K | -333K | -771K | -254K | -378K | -114K | -438K | -170K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.73M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -22K | -6K | -9K | -21K | n/a | n/a | n/a | -316K | -170K | -509K | -333K | -771K | -254K | -378K | -114K | -438K | -170K |
Debt Repayment | n/a | n/a | -7K | -21K | -3.35M | -1.69M | -2.24M | -1.13M | -1.69M | -21K | -22K | -21K | -21K | -22K | 287K | -354K | -21K |
Common Stock Repurchased | n/a | n/a | -4.27M | n/a | n/a | 194K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 5K | 8.2M | 4K | 17.55M | n/a | 54K | 8K | 140K | n/a | n/a | n/a | n/a | 16K | 115.85M | 14K | 5K | 25K |
Financial Cash Flow | 4.83M | 8.2M | -3K | 20.04M | 954K | -1.63M | -2.24K | -992 | -1.69K | -21K | -22K | -21K | -5K | 115.83M | 301K | -349K | 144.89M |
Net Cash Flow | 33.79M | -5.96M | -13.68M | 40.97M | -10.72M | -15.07M | -15.61M | -17.88M | -27.11M | -18.75M | -20.26M | -17.55M | -21.09M | 98.29M | -20.53M | -20.92M | 121.99M |
Free Cash Flow | 28.96M | -14.16M | -13.68M | 19.93M | -10.5M | -13.43M | -13.37M | -16.89M | -25.42M | -18.73M | -20.24M | -17.53M | -21.09M | -17.54M | -20.83M | -20.57M | -22.9M |